Clinical Trial

Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis

Study acronym: OASEQ
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to cast light on the highly complex etiology and cellular landscape of hip osteoarthritis by utilising single-cell and spatial omics.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-03-03; most recent amendment 2025-08-18.
Status change: Not Yet Recruiting → Recruiting 2022-11-01
Trial Details
NCT Number NCT05278520
Lead Sponsor University of Turku
Collaborators: Turku University Hospital, Hospital District of Helsinki and Uusimaa
Conditions Osteoarthritis, Hip, Rheumatoid Arthritis
Enrollment 110 participants
Start Date 2023-01-11
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-24